PURPOSE We aimed to evaluate the ability of 1H-magnetic resonance spectroscopy (1H-MRS) to detect and quantify hepatic fat content in vivo and ex vivo in an experimental rat model of alcoholic fatty liver using histopathology, biochemistry, and laboratory analyses as reference.METHODSAlcoholic fatty liver was induced within 48 hours in 20 Lewis rats; 10 rats served as control. In-trahepatic fat content determined by 1H-MRS was expressed as the percent ratio of the lipid and water peaks and was correlated with intrahepatic fat content determined histologically and biochemically. Liver enzymes were measured in serum.RESULTSFatty liver could be detected in vivo as well as ex vivo using 1H-MRS, in all 20 animals. Histologic analysis showed a fatty liver in 16 of 20 animals. Histology and 1H-MRS results were highly cor-related (in vivo, r=0.93, P = 0.0005; ex vivo, r=0.92, P = 0.0006). Also a strong correlation was noted between in vivo 1H-MRS measurements and the fat content determined biochemically (r=0.96, P = 0.0003). Ex vivo results showed a similarly strong correlation between 1H-MRS and biochem-istry (r=0.89, P = 0.0011).CONCLUSION1H-MRS can be carried out in ex vivo models, as well as in vivo, to detect and quantify intrahepatic fat content in the acute fatty liver.
Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006; 290:G852-858. [CrossRef]
Hubscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopatholo- gy 2006; 49:450-465.[CrossRef]
Smith EH. Complications of percutaneous ab- dominal fine-needle biopsy. Review. Radiology 1991; 178:253-258. [CrossRef]
Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 2005; 54:122-127. [CrossRef]
McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy - A matched case-control study. Ann Surg 2007; 245:923-930. [CrossRef]
Selzner M, Clavien PA. Fatty liver in liver trans- plantation and surgery. Semin Liver Dis 2001; 21:105-113. [CrossRef]
Todo S, Demetris AJ, Makowka L, et al. Primary nonfunction of hepatic allografts with preex- isting fatty infiltration. Transplantation 1989; 47:903-905. [CrossRef]
Ma X, Holalkere NS, Kambadakone RA, Mi- no-Kenudson M, Hahn PF, Sahani DV. Imag- ing-based quantification of hepatic fat: meth- ods and clinical applications. Radiographics 2009; 29:1253-1277. [CrossRef]
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcohol- ic fatty liver disease. Gastroenterology 2002;
Hatta T, Fujinaga Y, Kadoya M, et al. Accurate and simple method for quantification of he- patic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. J Gastroenterol 2010; 45:1263-1271. [CrossRef]
Chalasani N, Younossi Z, Lavine JE, et al. The di- agnosis and management of non-alcoholic fat- ty liver disease: Practice guideline by the Amer- ican Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 2012; 107:811-826. [CrossRef]
Ratner AV, Carter EA, Pohost GM, Wands JR. Nu- clear magnetic resonance spectroscopy and im- aging in the study of experimental liver diseases. Alcohol Clin Exp Res 1986; 10:241-245. [CrossRef]
Reboucas G, Isselbacher KJ. Studies on the patho- genesis of the ethanol-induced fatty liver. I. Syn- thesis and oxidation of fatty acids by the liver. J Clin Invest 1961; 40:1355-1362. [CrossRef]
Orlacchio A, Bolacchi F, Cadioli M, et al. Evalua- tion of the severity of chronic hepatitis C with 3-T1H-MR spectroscopy. AJR Am J Roentgenol 2008; 190:1331-1339. [CrossRef]
Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009; 250:95-102. [CrossRef]
Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of to- tal lipids from animal tissues. J Biol Chem 1957; 226:497-509.
Brunt EM. Nonalcoholic steatohepatitis: defi- nition and pathology. Semin Liver Dis 2001; 21:3-16. [CrossRef]
Theuer RC, Martin WH, Friday TJ, Zoumas BL, Sarett HP. Regression of alcoholic fatty liver in the rat by medium-chain triglycerides. Am J Clin Nutr 1972; 25:175-181.
Bode C, Kono H, Goebell H, Martini GA. Zur Pathogenese der Fetteinlagerung in die Leb- er durch Alkohol. Klin Wochenschr 1970; 19:1180-1188. [CrossRef]
Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis com- pared with liver biopsy: a meta-analysis. Eur Radiol 2011; 21:87-97. [CrossRef]
Mehta SR, Louise Thomas E, Patel N, et al. Pro- ton magnetic resonance spectroscopy and ul- trasound for hepatic fat quantification. Hepatol Res 2010; 40:399-406. [CrossRef]
Ratziu V, Charlotte F, Heurtier A, et al. Sam- pling variability of liver biopsy in nonalcohol- ic fatty liver disease. Gastroenterology 2005; 128:1898-1906. [CrossRef]
Turlin B, Ramm GA, Purdie DM, et al. Assess- ment of hepatic steatosis: comparison of quantitative and semiquantitative methods in 108 liver biopsies. Liver Int 2009; 29:530-535. [CrossRef]
Mennesson N, Dumortier J, Hervieu V, et al. Liver steatosis quantification using magnetic resonance imaging: a prospective compara- tive study with liver biopsy. J Comput Assist Tomogr 2009; 33:672-677. [CrossRef]
d'Assignies G, Ruel M, Khiat A, et al. Noninva- sive quantitation of human liver steatosis using magnetic resonance and bioassay methods. Eur Radiol 2009; 19:2033-2040. [CrossRef]
Hajek M, Dezortova M, Wagnerova D, et al. MR spectroscopy as a tool for in vivo determina- tion of steatosis in liver transplant recipients. MAGMA 2011; 24:297-304. [CrossRef]
Noworolski SM, Lam MM, Merriman RB, Ferrell L, Qayyum A. Liver steatosis: concordance of MR imaging and MR spectroscopic data with histologic grade. Radiology 2012; 264:88-96. [CrossRef]
Zhong L, Chen JJ, Chen J, et al. Nonalcoholic fatty liver disease: quantitative assessment of liver fat content by computed tomography, magnetic resonance imaging and proton mag- netic resonance spectroscopy. J Dig Dis 2009; 10:315-320. [CrossRef]
Choji T. Evaluation of fatty liver changes and fatty degeneration in liver tumors by 1H-MRS. Nihon Igaku Hoshasen Gakkai Zasshi 1993; 53:1408-1414.
Hamilton G, Middleton MS, Bydder M, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009; 30:145-152. [CrossRef]
Chabanova E, Bille DS, Thisted E, Holm JC, Thomsen HS. MR spectroscopy of liver in over- weight children and adolescents: Investigation of H-1 T-2 relaxation times at 3 T. Eur J Radiol 2012; 81:811-814. [CrossRef]
Murayama H, Ikemoto M, Hamaoki M. Orni- thine carbamyltransferase is a sensitive marker for alcohol-induced liver injury. Clin Chim Acta 2009; 401:100-104. [CrossRef]
Rosenthal P, Haight M. Aminotransferase as a prognostic index in infants with liver disease. Clin Chem 1990; 36:346-348.
Sorbi D, Boynton J, Lindor KD. The ratio of aspartate amino-transferase to alanine ami- notransferase: Potential value in differentiat- ing non- alcoholic steatohepatitis from alco- holic liver disease. Am J Gastroenterol 1999; 94:1018-1022. [CrossRef ]